García-Villarreal OA

Language: English
References: 5
Page: 1-2
PDF size: 1112.97 Kb.

Text Extraction

The Trilurninate Pivota! (NCT03904147) is a trial comparing the effectiveness of using transcatheter edge-to-edge therapy in tricuspid valve regurgitation (T-TEER) versus isolated medical treatment. Recently, Sorajja et al have published the results after one year of follow-up. In this study, a total of 350 patients were included; out of them, 175 were assigned to the device arm (T-TEER), and 175 to the medical treatment arm. Although 153 (87%) in the T-TEER group had preoperative atrial fibrillation, the authors do not mention whether any cases were due to atrial functional tricuspid regurgitation.

REFERENCES

1. l. Sora.üa P, Whisenant B, Hamid N, et al; TRH.,UMINATE Pivotal Investigators. Transcatheter Repair for Patients with Tricuspid Regurgitation. N Engl J Mee!. 2023;388(20):1833-1842. doi: 10.1056/NEJMoa2300525.

2. Rada G, RDa M. How t.o inte!pret composite outcomes.Rev Méd Chile 2009; 137:1523-1526. doi; 10.4067180034-98872009001100019.

3. https://www.nejm.org/doi/suppl/1O.1056/NEJMoa2300525/supp1_file/nejmoa2300525_apperutix.pdf. Last access Dec 03, 2023.

4. Spertus JA, Jones PG. Development and Validat:ion of a Short Version of the Kansas City Canliomyopathy Questiomutire. Circ Canliovasc Qua! Outcomes. 2015;8(5):469-76. doi: 10.1161/CIRCOUTCOMES.115.0019S8.

5. Gareia-Villarreal OA, Cepeda-Ayala GA. eComment. Beyond the 1riCW!pid annuloplasty teclmiques. Interact Cardiovasc Thonu: Surg. 2013;17(4):738. doi:10.1093/icvts/ivt359.